Navigation Links
Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market
Date:5/8/2013

NEW YORK, May 8, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market
http://www.reportlinker.com/p01172015/Analysis-of-the-US-Interventional-Radiology-and-Cardiology-X-ray-Equipment-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

New Growth Opportunities Emerge in a Mature Market

This research service pertains to the US market for interventional x-ray equipment used in radiology and cardiology. A thorough market sizing and forecasting model of market revenue, unit shipments, and pricing is included, along with analyses of technology trends, market drivers and restraints, and the competitive environment. The two market segments considered are interventional radiology (IR) and interventional cardiology (IC). The study also covers clinical specialties utilizing high-end interventional x-ray equipment, such as neurology and oncology. The base year of the study is 2012; the forecast period extends through 2019.

Executive Summary

• Interventional x-ray equipment has been widely adopted by U.S. hospitals over the last 20 years, especially in the areas of radiology and cardiology.
• The large installed base of equipment existing within a finite addressable market space creates a highly penetrated, mature, mainly replacement market.
• This high degree of market maturity prevails mainly within the traditional interventional radiology (IR) and interventional cardiology (IC) markets.
• The size of both the IR and IC segments has contracted during the last three years, owing to macroeconomic pressures coupled with a slowdown in replacement cycles.
• While the revenue opportunity seems to have adjusted to a new lower level, the market outlook seemed to be reverting back to positive levels starting in the second half of 2012. This positive traction is due to the fact that both the IR and IC market segments also comprise smaller sub-segments that offer significant growth opportunities.
• Such is the case of interventional oncology and interventional neurology, two sub-segments of IR that are poised to pursue their current growth dynamics.
• Similarly, certain sub-segments of the IC market such as electrophysiology (EP) and other emerging minimally invasive procedures continue to exhibit robust growth.
• Combined, these growth pockets hold the promise of offsetting some of the recent growth decays in the mature market segments, keeping the overall growth dynamics positive.
• More so than the growth pockets driving, respectively, the IR and IC markets, it is the combined demand from these two segments that is creating the highest synergies.
• As combo catheterization suites and hybrid operating rooms (OR) slowly emerge as a clinical best practice, they are driving demand for multipurpose interventional equipment.
• The recovery of market growth is expected to be gradual, as installed base equipment lifecycles decay from the current X to X years toward seven to Xyears, as in the past.
• This revival of replacement cycles will hinge on technology advances that pertain to the usability of equipment in these complex environments and combine multiple modalities.

CEO's Perspective

1. Replacement cycles are lengthening in mature segments, while emerging markets and procedures are offsetting part of the slowdown.
2. Product and technology innovation cycles are lengthening due to mounting market and industry pressures.
3. Technology advancement persists in advanced multimodality image guidance and visualization.
4. Clinical guidelines continue to drive procedures toward noninvasive diagnostic and minimally invasive interventional techniques.
5. Hybrid operating rooms and combination cath labs will emerge as clinical best practices, reviving market growth.

Key Questions This Study Will Answer

• Is the recent market slowdown and ensuing revenue decline a permanent one? Will the downward trend continue or give way to a more stable or increasing growth pattern?
• Which growth segments of the market are most likely to accelerate the recovery of historic market size and growth rates, and over which period of time?
• What are the key product technologies that have helped to revive legacy system replacement cycles and are likely to impact future market growth in the U.S. marketplace?
• What are the main current and future developments in clinical guidelines expected to play a role either in favor or to the detriment of interventional x-ray equipment adoption?
• What type of impact is the trend toward the development of hybrid operating rooms (OR) and combo cath labs expected to have on the evolution of the customer and market landscape?
• What is the outlook on the current industry dynamics, and is the current concentration around the top three market participants likely to increase, or is the market more likely to diversify?





Table Of Contents

1. Executive Summary
2. Market Overview
3. Total Interventional Radiology and Cardiology X-ray Equipment Market
• External Challenges: Drivers and Restraints
• Forecast and Trends
• Demand Analysis
• Market Share and Competitive Analysis
4. Interventional Radiology Segment Breakdown
5. Interventional Cardiology Segment Breakdown
6. The Last Word
7. Appendix


To order this report:
: Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
2. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
3. Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting
4. Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
5. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
6. Small Animal Imaging (In Vivo) Market - By systems and reagents - Competitive Analysis & Global Forecasts to 2017
7. 2013 BRIC Medical Devices Market & CIVETS Medical Equipment Industry Analysis
8. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
9. Antibody Technologies and Attrition Rates - An Industry Analysis 2013
10. Medical Equipment Monthly Deals Analysis: February 2013 - M&A and Investment Trends
11. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
Breaking Medicine Technology:
(Date:4/24/2017)... , ... April 24, 2017 , ... Ridgecrest Herbals makes ... sustainability, innovate new strategies to reduce waste, and support renewable energy. They believe this ... look to nature to find solutions for health issues, and maintain that destroying the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Today, Bright Pink , a national non-profit organization focusing ... a new CEO. , Bright Pink is proud to announce Katie Thiede as their ... to a new role as Chairman of the Board and launched a national search ...
(Date:4/24/2017)... ... 2017 , ... The John P. McGovern Museum of Health and Medical Science ... their cognitive health, and share results with their physicians. Members and guests can sign ... website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... advisor within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched ... providers. Available 24 hours a day, Quick Care provides patients with the option ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health ... anxiety levels in people with addiction who are served by MAP’s patient engagement ... wearable device that monitors heart and breath rates to identify anxiety levels and ...
Breaking Medicine News(10 mins):